Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Calibration × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

Magnetic Resonance Spectroscopy 119 Specimen Handling 109 pembrolizumab 103 Cyclophosphamide 86 Radiotherapy 75 Nivolumab 73 Cisplatin 61 Biopsy 59 Carboplatin 58 Gemcitabine 52 fludarabine 51 Surveys and Questionnaires 51 Radiosurgery 50 Blood Specimen Collection 49 venetoclax 45 Standard of Care 45 Paclitaxel 41 Radiation 38 Rituximab 37 Dexamethasone 37 Ipilimumab 35 Cytarabine 34 Bevacizumab 34 Docetaxel 32 fludarabine phosphate 31 Oxaliplatin 31 Drug Therapy 31 durvalumab 30 Interviews as Topic 30 Taxes 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483723 2026-03-19

PROGLYSOPK

Centre Hospitalier Universitaire, Amiens

Phase NA Recruiting

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡